XLON
AOTI
, Last price
GBX
Name
Aoti Inc
Chart & performance
P/E
—
P/S
—
EPS
0.03
Vol. 1Y
—
Shs. 5Y
—
Rev. 5Y
%
Div Yld LY
—
Div Yld TTM
—
Revenues
69m
+17.89%
Net income
3m
P
CFO
-5m
L-16.11%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
AOTI, Inc. specializes in creating and marketing healthcare technologies specifically designed for treating persistent and hard-to-heal wounds. Among its offerings are the innovative Topical Wound Oxygen (TWO2) Therapy and the NEXA Negative Pressure Wound Therapy (NPWT) System. Michael Stephen Griffiths founded the company in 2006, and its main office is located in Oceanside, California.
Legal address
7901 4TH ST N, STE 300, ST. PETERSBURG
ST. PETERSBURG, FL 33702
US
ST. PETERSBURG, FL 33702
US
Headquarters
3512 SEAGATE WAY, STE 100, OCEANSIDE
OCEANSIDE, CA 92056
US
OCEANSIDE, CA 92056
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | |
| Income | |||||
Revenues | |||||
Cost of revenue | |||||
Unusual Expense (Income) | |||||
NOPBT | |||||
NOPBT Margin | |||||
Operating Taxes | |||||
Tax Rate | |||||
NOPAT | |||||
Net income | |||||
Dividends | |||||
Dividend yield | |||||
Proceeds from repurchase of equity | |||||
BB yield | |||||
| Debt | |||||
Debt current | |||||
Long-term debt | |||||
Deferred revenue | |||||
Other long-term liabilities | |||||
Net debt | |||||
| Cash flow | |||||
Cash from operating activities | |||||
CAPEX | |||||
Cash from investing activities | |||||
Cash from financing activities | |||||
FCF | |||||
| Balance | |||||
Cash | |||||
Long term investments | |||||
Excess cash | |||||
Stockholders' equity | |||||
Invested Capital | |||||
ROIC | |||||
ROCE | |||||
| EV | |||||
Common stock shares outstanding | |||||
Price | |||||
Market cap | |||||
EV | |||||
EBITDA | |||||
EV/EBITDA | |||||
Interest | |||||
Interest/NOPBT | |||||